Stage IV Breast Cancer

Oncology

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

29 drugs in development·4 companies·5 clinical trials

Drug Pipeline by Phase

Phase 2(15)
DrugCompany
Anti-CD40 Agonist Monoclonal Antibody CDX-1140UNITED THERAPEUTICS Corp (UTHR)
Anti-HER2/HER3 Dendritic Cell VaccineUNITED THERAPEUTICS Corp (UTHR)
Anti-PD-1 monoclonal antibodyUNITED THERAPEUTICS Corp (UTHR)
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA VaccineUNITED THERAPEUTICS Corp (UTHR)
Dendritic Cell VaccineUNITED THERAPEUTICS Corp (UTHR)
Immune Checkpoint InhibitorENANTA PHARMACEUTICALS INC (ENTA)
Personalized Synthetic Long Peptide VaccineENANTA PHARMACEUTICALS INC (ENTA)
Poly ICLCENANTA PHARMACEUTICALS INC (ENTA)
pTVG-HP DNA vaccineUNITED THERAPEUTICS Corp (UTHR)
sacituzumab govitecanGH Research PLC (GHRS)
Sacituzumab GovitecanENANTA PHARMACEUTICALS INC (ENTA)
Smallpox and Mpox VaccineUNITED THERAPEUTICS Corp (UTHR)
TremelimumabADMA BIOLOGICS, INC. (ADMA)
TremelimumabENANTA PHARMACEUTICALS INC (ENTA)
WOKVAC VaccineUNITED THERAPEUTICS Corp (UTHR)

Compare drugs

cyclin-dependent kinase 4 inhibitor vs cyclin-dependent kinase 6 inhibitorcyclin-dependent kinase 4 inhibitor vs Gardasill 9™ vaccinecyclin-dependent kinase 4 inhibitor vs her2-targeted therapy

Frequently asked questions

How many drugs are in development for Stage IV Breast Cancer?

BioSniper tracks 29 drugs in development for Stage IV Breast Cancer across 4 companies.

How many clinical trials target Stage IV Breast Cancer?

There are 5 clinical trials targeting Stage IV Breast Cancer tracked by BioSniper.

What is the prevalence of Stage IV Breast Cancer?

The estimated prevalence of Stage IV Breast Cancer is approximately 287.0 per 100,000 population.

Deep-dive into Stage IV Breast Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Stage IV Breast Cancer — Drugs in Development & Clinical Trials | BioSniper